Is there anyone here from Norway?
I’ve tried to find a Norwegian ME group to ask there but came up empty (I’m sure there are some, just didn’t find them).
https://clinicaltrials.gov/ct2/show/NCT03691987
I’m interested if there are already some anecdotes of study-participants of this FMT study. Especially interested in outcomes of severe patients, patients with IgG def (are these excluded because possibly fitting under “immuno-compromised”?, patients who’s main/worst symptoms are not GI symptoms, patients that benefited and met the ICC.
Is LDN only an excluding factor because they want to make sure they can PinPoint effects or can LDN effects actually interfere with FMT?
I’ve tried to find a Norwegian ME group to ask there but came up empty (I’m sure there are some, just didn’t find them).
https://clinicaltrials.gov/ct2/show/NCT03691987
I’m interested if there are already some anecdotes of study-participants of this FMT study. Especially interested in outcomes of severe patients, patients with IgG def (are these excluded because possibly fitting under “immuno-compromised”?, patients who’s main/worst symptoms are not GI symptoms, patients that benefited and met the ICC.
Is LDN only an excluding factor because they want to make sure they can PinPoint effects or can LDN effects actually interfere with FMT?